TT(人骨髓样甲状腺癌细胞)1803

TT(人骨髓样甲状腺癌细胞)1803Cell Biology

ATCC® Number: CRL-1803™ Price:
Designations: TT Depositors: SS Leong
Biosafety Level: 1 Shipped: frozen
Medium & Serum: See Propagation Growth Properties: adherent
Organism: Homo sapiens (human) Morphology: epithelial

TT(人骨髓样甲状腺癌细胞)1803 Source: Organ: thyroid
Tissue: medulla
Disease: carcinoma
Cellular Products: calcitonin; carcinoembryonic antigen (CEA) [21867]
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Related Cell Culture Products
Tumorigenic: Yes, Tumors developed within 21 days at 100% frequency (5/5) in nude mice inoculated subcutaneously with 10(7) cells.
DNA Profile
(STR): Amelogenin: X
CSF1PO: 10,13
D13S317: 11
D16S539: 12,13
D5S818: 12,13
D7S820: 10,12
THO1: 6,9
TPOX: 8,11
vWA: 16,18
Cytogenetic
Analysis: aneuploid with several markers; modal number = 40; range = 32 to 86 [21867]
Age: 77 years
Gender: female
Ethnicity: Caucasian
Comments: The TT cell line was established by S.S. Leong, et al. from a specimen obtained by needle biopsy from a 77 year old female with thyroid medullary carcinoma. [21867]
TT cells continuously produce high levels of calcitonin and CEA. [21867]
Immunoreactive calcitonin was found to be produced in cell culture at levels of 3900 pg/million cells and 7700 pg/million cells 24 and 72 hours respectively after a medium change. [21867]
CEA was found to accumulate to greater than 27 ng/million cells over a 72 hours period. [21867]
Chromosomal analysis of the cell line and tumors induced in nude mice reveal an aneuploid human karyotype with several marker chromosomes. [21867]
The initial characterization studies of the TT cell line were conducted using early passage TT cells cultivated in RPMI 1640 medium supplemented with 15% fetal bovine serum and 1 mM L-glutamine.
It is not known if the neuropeptides reported to be produced by this cell line when it was grown in RPMI 1640 medium are also produced by the cells when they are cultured in Ham＇s F12K medium.
Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated F-12K Medium, Catalog No. 30-2004. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Temperature: 37.0C
Subculturing: Remove medium, and rinse with 0.25% trypsin, 0.03% EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach.
Add fresh culture medium, aspirate and dispense into new culture flasks.
Subcultivation ratio: A subcultivation ratio of 1:3 to 1:4 is recommended

Medium renewal: Twice per week

TT(人骨髓样甲状腺癌细胞)1803 Preservation: Culture medium, 95%; DMSO, 5%
Doubling Time: 83 hrs
Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium): ATCC 30-2004
recommended serum: ATCC 30-2020
References: 21867: Robbins J , et al, editors. Advances in thyroid neoplasia, 1981. Rome: Field Educational Italia; 1981, pp. 95-105.
32264: Behr TM , et al. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type. Cancer Res. 57: 5309-5319, 1997. PubMed: 9393755

TT(人骨髓样甲状腺癌细胞)1803 其他产品　消化系统细胞株

TC-hxbz-001人口腔表皮样癌细胞KB

TC-hxbz-002人口腔上皮癌长春新碱耐药株KB/V

TC-hxbz-003人口腔癌细胞HB

TC-hxbz-004人喉表皮样癌细胞HEp-2

TC-hxbz-005人咽鳞癌细胞FaDu

TC-hxbz-006人喉癌细胞TU 686

TC-hxbz-007人喉癌细胞TU212

TC-hxbz-008人喉癌细胞M2e

TC-hxbz-009人喉癌细胞M4e

TC-hxbz-010人食管癌细胞Eca-109

TC-hxbz-011人食管癌细胞EC871214

TC-hxbz-012人食管癌细胞CaEs-17

TC-hxbz-013人食管癌细胞TE-1

TC-hxbz-014人食管癌细胞TE-10

TC-hxbz-015人食管癌细胞TE-11

TC-hxbz-016人食管癌细胞EC97076

TC-hxbz-017人食管鳞癌KYSE 150

TC-hxbz-018人食管鳞癌KYSE 450

TC-hxbz-019人食管鳞癌KYSE30

TC-hxbz-020人食管鳞癌KYSE70

TC-hxbz-021人食管癌细胞KYSR450

TC-hxbz-022人食管癌细胞KYSE510

TC-hxbz-023人胃癌细胞系HS⁻⁷46T

TC-hxbz-024人胃癌细胞BSG823

TC-hxbz-025人胃粘膜细胞GES-1

TC-hxbz-026人胃腺癌细胞MGC-803

TC-hxbz-027人胃腺癌细胞MCG803

TC-hxbz-028人低分化胃癌细胞BGC-823

TC-hxbz-029人低分化胃癌细胞SGC7901

TC-hxbz-030人耐VCR胃腺癌细胞SGC⁻⁷901/VCR

TC-hxbz-031人低分化胃癌细胞MKN-45

TC-hxbz-032人未分化胃癌细胞HGC-27

TC-hxbz-033人胃腺癌细胞AGS

TC-hxbz-034人胃腺癌细胞NCI-N87

TC-hxbz-035人胃癌细胞MKN-28

TC-hxbz-036人胃癌细胞(+)9811

TC-hxbz-038人胃癌细胞9811C11

TC-hxbz-039绿色荧光蛋白标记人胃癌细胞MGC803-GFP